SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-146162
Filing Date
2020-05-19
Accepted
2020-05-19 16:19:38
Documents
50
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 6-K d931450d6k.htm 6-K 12835
2 EX-99.1 d931450dex991.htm EX-99.1 186122
3 EX-99.2 d931450dex992.htm EX-99.2 68822
4 EX-99.3 d931450dex993.htm EX-99.3 91582
  Complete submission text file 0001193125-20-146162.txt   1869884

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ncna-20200331.xml EX-101.INS 329583
6 XBRL TAXONOMY EXTENSION SCHEMA ncna-20200331.xsd EX-101.SCH 22497
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ncna-20200331_cal.xml EX-101.CAL 28720
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ncna-20200331_def.xml EX-101.DEF 51475
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ncna-20200331_lab.xml EX-101.LAB 161952
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ncna-20200331_pre.xml EX-101.PRE 129369
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 20893867
SIC: 2834 Pharmaceutical Preparations